MoneyWorks4Me

Kimia Biosciences informs about updates

29 Apr 2020 Evaluate

Kimia Biosciences has informed that the Company has been granted permission to Manufacturing and Marketing of New Active pharmaceutical Ingredient Azelnidipine drug by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi - 110002 (India) Vide permission No. MF/SND/20/000114 dated 28-April-2020 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..